LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis

International Journal of Biological Macromolecules
Hai GaoGong Zhang

Abstract

Recently, lncRNA ZEB2-AS1 was identified as a lncRNA that promoted cancer progression. However, the biological function and the underlying mechanism of ZEB2-AS1 in pancreatic cancer had not been reported. In the current study, we revealed that the expression level of ZEB2-AS1 was elevated in pancreatic cancer cell lines and tissues. ZEB2-AS1 inhibition decreased cell growth and invasion in pancreatic cancer. Mechanismly, ZEB2-AS1 exerted as a ceRNA and negatively regulated miR-204 expression. In addition, HMGB1 was identified as a down-stream target of miR-204. The miR-204/HMGB1 axis mediated ZEB2-AS1's effect on pancreatic cancer. Our findings revealed that lncRNA ZEB2-AS1 may be a candidate prognostic biomarker and a target for new therapies in pancreatic cancer patients.

Citations

Nov 27, 2019·Technology in Cancer Research & Treatment·Xinquan WuKuirong Jiang
Nov 23, 2019·Cancer Biotherapy & Radiopharmaceuticals·Yinghao JiangXia Li
Oct 4, 2019·Oncology Letters·Yinghao Lv, Shuai Huang
Jul 21, 2020·IUBMB Life·Zarei MahboobehShekari Mohammad
Oct 28, 2020·Journal of Cellular Physiology·Jiaming XueHaining Yang
Jan 7, 2021·Journal of Assisted Reproduction and Genetics·Yingliu LuoCuilian Zhang
Jan 29, 2021·BioMed Research International·Mengsi YuZhaoxia Zhang
May 27, 2021·Transcription·K T Ramya DeviSanjana Prakash Hemdev
Jun 20, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kailiang LiPengyuan Zheng
Aug 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lei CaoJianhua Huang

❮ Previous
Next ❯

Related Concepts